PL3689341T3 - Gabapentyna okulistyczna do leczenia deepitelializacji rogówki - Google Patents

Gabapentyna okulistyczna do leczenia deepitelializacji rogówki

Info

Publication number
PL3689341T3
PL3689341T3 PL20160507.8T PL20160507T PL3689341T3 PL 3689341 T3 PL3689341 T3 PL 3689341T3 PL 20160507 T PL20160507 T PL 20160507T PL 3689341 T3 PL3689341 T3 PL 3689341T3
Authority
PL
Poland
Prior art keywords
epithelialization
gabapentin
corneal
ophthalmic
treatment
Prior art date
Application number
PL20160507.8T
Other languages
English (en)
Inventor
Piero Biondi
Edoardo Stagni
Original Assignee
Fidia Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici S.P.A. filed Critical Fidia Farmaceutici S.P.A.
Publication of PL3689341T3 publication Critical patent/PL3689341T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20160507.8T 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia deepitelializacji rogówki PL3689341T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000121A ITUB20160121A1 (it) 2016-01-29 2016-01-29 Gabapentina oftalmica per il trattamento di ulcere corneali

Publications (1)

Publication Number Publication Date
PL3689341T3 true PL3689341T3 (pl) 2024-04-22

Family

ID=55860930

Family Applications (2)

Application Number Title Priority Date Filing Date
PL20160507.8T PL3689341T3 (pl) 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia deepitelializacji rogówki
PL17703933T PL3407879T3 (pl) 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia wrzodów rogówki

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17703933T PL3407879T3 (pl) 2016-01-29 2017-01-25 Gabapentyna okulistyczna do leczenia wrzodów rogówki

Country Status (8)

Country Link
EP (2) EP3689341B1 (pl)
AR (1) AR107460A1 (pl)
ES (2) ES2971979T3 (pl)
IT (1) ITUB20160121A1 (pl)
PL (2) PL3689341T3 (pl)
PT (1) PT3407879T (pl)
SM (1) SMT202100183T1 (pl)
WO (1) WO2017129577A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2664693C1 (ru) * 2017-10-05 2018-08-21 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ предоперационной подготовки пациентов к офтальмологическим операциям
US20230302032A1 (en) * 2020-08-04 2023-09-28 Harrow Ip Llc Antibacterial compositions and methods for fabricating thereof
US20240139136A1 (en) * 2021-02-26 2024-05-02 Vyluma Inc. Methods and formulations for topical administration of gabapentinoids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2316420B1 (en) * 2009-10-22 2014-02-26 Consorzio Universitario Unifarm Topical ophthalmic composition to reduce pain
EP2851063A1 (en) 2013-09-19 2015-03-25 Consorzio Universitario Unifarm Gabapentin compositions for treating or preventing ocular pain

Also Published As

Publication number Publication date
ES2971979T3 (es) 2024-06-10
PL3407879T3 (pl) 2021-06-28
EP3407879B1 (en) 2021-01-06
EP3407879A1 (en) 2018-12-05
SMT202100183T1 (it) 2021-05-07
EP3689341A1 (en) 2020-08-05
ITUB20160121A1 (it) 2017-07-29
ES2862324T3 (es) 2021-10-07
AR107460A1 (es) 2018-05-02
PT3407879T (pt) 2021-03-31
WO2017129577A8 (en) 2017-10-19
WO2017129577A1 (en) 2017-08-03
EP3689341B1 (en) 2023-12-20

Similar Documents

Publication Publication Date Title
IL288712B1 (en) Methods for treating abnormal movement disorders
LT3122878T (lt) Terapija mrnr, skirta akių ligų gydymui
IL248732A0 (en) Compounds for the treatment of ophthalmological diseases and disorders
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3212233A4 (en) Combination therapy for treatment of disease
SG11201608729RA (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
PL3419622T3 (pl) Leczenie neurodegeneracyjnej choroby oczu przy użyciu pridopidyny
PL3210973T3 (pl) Związki heteroarylowe do leczenia chorób oczu
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
IL269698B (en) Methods for preventing or treating eye diseases
PL3689341T3 (pl) Gabapentyna okulistyczna do leczenia deepitelializacji rogówki
IL259381B (en) Mirabegron for the treatment of retinal diseases
IL263837A (en) Treatment of ocular disease
EP3284475A4 (en) Agent for prevention or treatment of corneal disorders
EP3238723A4 (en) Drug for treating disorders of corneal epithelium
HUE060927T2 (hu) N,N-bisz-2-merkaptoetil-izoftálamid neurodegeneratív betegségek kezelésére
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
HK40092417A (zh) 用於治疗眼科疾病和障碍的化合物
GB201610938D0 (en) Treatment of ocular disease